US 8536149
TRPM-2 antisense therapy
granted A61KA61K31/00A61K31/337
Quick answer
US patent 8536149 (TRPM-2 antisense therapy) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/00, A61K31/337, A61K31/66, A61K31/704